SERPINA9

protein-coding

serpin family A member 9, the group of Serpin peptidase inhibitors

Gene summary

Enables serine-type endopeptidase inhibitor activity. Predicted to be located in cytoplasm; extracellular region; and membrane. Predicted to be active in obsolete extracellular space. [provided by Alliance of Genome Resources, Jun 2026]

MANE transcript

NM_175739.4

Inheritance

—

ClinVar variants

U:93B:7

Top phenotype

—

gnomAD constraint

pLI —, LoF o/e 1.39

Max pathogenic AF

—

Genomic locus

chr14:94,462,717-94,479,689

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~17.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

No GenCC data available for this gene.

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to SERPINA9 variants in ClinVar

2 Conditions Cataloged
not specifiedTotal: 96
not providedTotal: 1

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_175739.4. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
0
missense
91
clinvar
6
clinvar
1
clinvar
98
nonsense
1
clinvar
1
start loss
0
frameshift
0
splice donor/acceptor (+/-2bp)
1
clinvar
1
Total009361100
Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 25 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_175739.4RefSeqNP_783866.34MANE Select
ENST00000674397.2EnsemblENSP00000501517.14MANE Select
NM_001042518.2RefSeqNP_001035983.25Standard
NM_001284275.2RefSeqNP_001271204.24Standard

Gene Ontology (GO) Annotations & Pathways

Biological processes, molecular functions, cellular components and pathways

Biological Process

  • negative regulation of endopeptidase activity

Molecular Function

  • serine-type endopeptidase inhibitor activity

Cellular Component

  • extracellular space
  • cytoplasm
  • membrane

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000337425
Coding exons
5
Length
16973
Individuals with no LoFs
121433
Homozygous LoFs
73
Heterozygous LoFs
3319
Defined
124825
p
0.0137
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-1.112752281.210.00001122851
Missense (PolyPhen)7366.7141.0942903
Synonymous-1.9511692.21.260.00000479873
Loss of Function-1.261712.21.395.19e-7158

Population LoF Frequency

PopulationCAFp-valueStatus
African0.140.14notable
Latino/Admixed American0.0120.012notable
Ashkenazi Jewish0.0190.018notable
East Asian0.000830.00083rare
Finnish0.00160.0016notable
European (Non-Finnish)0.00550.0055notable
South Asian0.000790.00078rare
Other0.0130.012notable

dbNSFP Gene Annotations

Source: dbNSFP

Function
FUNCTION: Protease inhibitor that inhibits trypsin and trypsin- like serine proteases (in vitro). Inhibits plasmin and thrombin with lower efficiency (in vitro). {ECO:0000269|PubMed:17447896}.;

Recessive Scores

pRec
0.0945

Intolerance Scores

LoFtool
0.111
RVIS EVS
2.78
RVIS percentile EVS
99.02

Essentials

Essential (CRISPR)
N
Essential (CRISPR2)
N
Essential (gene trap)
N
Indispensability pred.
N
Indispensability score
0.0537

Gene Damage Prediction

AllRecessiveDominant
MendelianHighHighHigh
Primary ImmunodeficiencyHighHighHigh
CancerHighHighHigh
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.